By Natalie Rahhal
AstraZeneca (click here) expects to get US emergency authorization for its COVID-19 vaccine in April, the firm's president told lawmakers on Tuesday.
As soon as it gets the Food and Drug Administration's (FDA) greenlight, AstraZeneca will have 30 million doses of the 62 percent effective shot ready to ship to the US, said president of the biopharmaceuticals arm of the company, Dr Ruud Dobber on Tuesday.
He told members of the House of Representatives' Committee on Energy and Commerce that the company could deliver 'up to 50 million' doses by the end of April...
As soon as it gets the Food and Drug Administration's (FDA) greenlight, AstraZeneca will have 30 million doses of the 62 percent effective shot ready to ship to the US, said president of the biopharmaceuticals arm of the company, Dr Ruud Dobber on Tuesday.
He told members of the House of Representatives' Committee on Energy and Commerce that the company could deliver 'up to 50 million' doses by the end of April...
